Impact of sentinel lymph node biopsy on lymphedema following breast cancer treatment [4]

Breast Journal

Volumn 11, Issue 5, 2005, Pages 370-371

  Soran, Atilla ^a   Aydin, Cengiz ^b   Harlak, Ali ^a   Vogel, Victor G ^a   Johnson, Ronald ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARM EDEMA; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CANCER STAGING; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LETTER; LYMPH NODE DISSECTION; LYMPHEDEMA; MASTECTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY; SEROMA; ADULT; AGED; AXILLA; BREAST TUMOR; COMPARATIVE STUDY; FEMALE; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RISK ASSESSMENT;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHEDEMA; MIDDLE AGED; NEOPLASM INVASIVENESS; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY;

EID: 27744505803     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2005.21717.x     Document Type: Letter

References (14)

1. Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000;88:608-14.
2. Kocak Z, Overgaard J. Risk factors of arm lymphedema in breast cancer patients. Acta Oncol 2000;39:389-92.
3. Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 2001;92:748-52.
4. Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer [comment]. J Clin Oncol 2000;18:2553-59;
5. erratum J Clin Oncol 2000;18:3877.
6. Temple LK, Baron R, Cody HS 3rd, et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 2002;9:654-62.
7. Burak WE, Hollenbeck ST, Zervos EE, et al. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 2002;183:23-27.
8. Blanchard DK, Donohue JH, Reynolds C, Grant CS. Morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003;138:482-88.
9. Schijven MP, Vingerhoets AJ, Rutten HJ, et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003;29:341-50.
10. Golshan M, Martin WJ, Dowlatshahi K. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg 2003;69:209-11.
11. Ardic F, Soran A, D'Angelo D, et al. Lymphedema in women undergoing breast cancer surgery: what are the significant predictors? Breast J 2001;7(5 Suppl):32. Abstract.
12. Tengrup I, Tennvall-Nittby L, Christiansson I, et al. Arm morbidity after breast-conserving therapy for breast cancer. Acta Oncol 2000;39:393-97.
13. Werner RS, McCormick B, Petrek J, et al. Arm edema in conservatively managed breast cancer: obesity is a major predictive factor. Radiology 1991;180:177-84.
14. Mortimer PS, Bates DO, Brassington HD, et al. The prevalence of arm edema following treatment for breast cancer. Q J Med 1996;89:377-80.